Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Irbesartan Patent Expiration

Irbesartan was first introduced by Sanofi Aventis Us Llc in its drug Avapro on Sep 30, 1997. 23 different companies have introduced drugs containing Irbesartan.


Irbesartan Patents

Given below is the list of patents protecting Irbesartan, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Avapro US6342247

(Pediatric)

 Pharmaceutical compositions containing irbesartan Dec 07, 2015

(Expired)

 Sanofi Aventis Us
Avapro US6342247 Pharmaceutical compositions containing irbesartan Jun 07, 2015

(Expired)

 Sanofi Aventis Us



Irbesartan's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Irbesartan Generic API Manufacturers

Several generic applications have been filed for Irbesartan. The first generic version for Irbesartan was by Teva Pharmaceuticals Usa and was approved on Mar 30, 2012. And the latest generic version is by Ipca Laboratories Ltd and was approved on May 22, 2024.

Given below is the list of companies who have filed for Irbesartan generic, along with the locations of their manufacturing plants worldwide.


1. AJANTA PHARMA LTD

Ajanta Pharma Ltd has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Ajanta Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
75MG

tablet Discontinued ORAL N/A Dec 10, 2015
150MG

tablet Discontinued ORAL N/A Dec 10, 2015
300MG

tablet Discontinued ORAL N/A Dec 10, 2015


Manufacturing Plant Locations
New

Ajanta Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Ajanta Pharma Ltd as present at those locations.

Country City Firm Name
India
Aurangabad Ajanta Pharma Ltd.





2. ALEMBIC PHARMS LTD

Alembic Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Alembic Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
75MG

tablet Prescription ORAL AB Oct 15, 2012
150MG

tablet Prescription ORAL AB Oct 15, 2012
300MG

tablet Prescription ORAL AB Oct 15, 2012





3. AMNEAL PHARMS

Amneal Pharmaceuticals Of New York Llc has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Amneal Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
75MG

tablet Prescription ORAL AB Apr 17, 2018
150MG

tablet Prescription ORAL AB Apr 17, 2018
300MG

tablet Prescription ORAL AB Apr 17, 2018





4. APOTEX INC

Apotex Inc has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Apotex Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
75MG

tablet Discontinued ORAL N/A Oct 15, 2012
150MG

tablet Discontinued ORAL N/A Oct 15, 2012
300MG

tablet Discontinued ORAL N/A Oct 15, 2012


Manufacturing Plant Locations
New

Apotex Inc's manufacturing plants are situated in 1 country - Canada. Given below are the details of these plant locations as well as the firm names of Apotex Inc as present at those locations.

Country City Firm Name
Canada
Toronto Apotex Inc.
North York Apotex Inc.
Richmond Hill Apotex Inc.





5. AUROBINDO PHARMA LTD

Aurobindo Pharma Ltd has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
75MG

tablet Prescription ORAL AB Sep 27, 2012
300MG

tablet Prescription ORAL AB Sep 27, 2012
150MG

tablet Prescription ORAL AB Sep 27, 2012


Manufacturing Plant Locations
New

Aurobindo Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Ltd as present at those locations.

Country City Firm Name
India
Medchal Aurobindo Pharma Ltd





6. CHARTWELL MOLECULAR

Chartwell Molecular Holdings Llc has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Chartwell Molecular.

Strength Dosage Form Availability Application Pathway TE code Launch Date
300MG

tablet Prescription ORAL AB Nov 14, 2012
150MG

tablet Prescription ORAL AB Nov 14, 2012
75MG

tablet Prescription ORAL AB Nov 14, 2012





7. CHARTWELL RX

Chartwell Rx Sciences Llc has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Chartwell Rx.

Strength Dosage Form Availability Application Pathway TE code Launch Date
300MG

tablet Discontinued ORAL N/A Sep 27, 2012
150MG

tablet Discontinued ORAL N/A Sep 27, 2012
75MG

tablet Discontinued ORAL N/A Sep 27, 2012





8. HETERO LABS LTD V

Hetero Labs Ltd Unit V has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd V.

Strength Dosage Form Availability Application Pathway TE code Launch Date
75MG

tablet Prescription ORAL AB Sep 27, 2012
150MG

tablet Prescription ORAL AB Sep 27, 2012
300MG

tablet Prescription ORAL AB Sep 27, 2012





9. HIKMA

Hikma Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Hikma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
150MG

tablet Discontinued ORAL N/A Oct 15, 2012
75MG

tablet Discontinued ORAL N/A Oct 15, 2012
300MG

tablet Discontinued ORAL N/A Oct 15, 2012


Manufacturing Plant Locations
New

Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.

Country City Firm Name
United States
Dayton Hikma Injectables USA Inc
Cherry Hill Hikma Pharmaceuticals USA Inc.
Eatontown Hikma Pharmaceuticals USA, Inc.
Carlsbad Hikma Cali Inc. DBA Leucadia Pharmaceuticals
Portugal
Terrugem Snt Hikma Farmaceutica, (Portugal) S.A.
Jordan
Amman Hikma Pharmaceuticals LLC





10. HISUN PHARM HANGZHOU

Hisun Pharmaceutical (hangzhou) Co Ltd has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Hisun Pharm Hangzhou.

Strength Dosage Form Availability Application Pathway TE code Launch Date
75MG

tablet Prescription ORAL AB Jun 14, 2016
300MG

tablet Prescription ORAL AB Jun 14, 2016
150MG

tablet Prescription ORAL AB Jun 14, 2016





11. IPCA LABS LTD

Ipca Laboratories Ltd has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Ipca Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
75MG

tablet Prescription ORAL AB May 22, 2024
150MG

tablet Prescription ORAL AB May 22, 2024
300MG

tablet Prescription ORAL AB May 22, 2024





12. JUBILANT GENERICS

Jubilant Generics Ltd has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Jubilant Generics.

Strength Dosage Form Availability Application Pathway TE code Launch Date
75MG

tablet Prescription ORAL AB Feb 23, 2015
150MG

tablet Prescription ORAL AB Feb 23, 2015
300MG

tablet Prescription ORAL AB Feb 23, 2015


Manufacturing Plant Locations
New

Jubilant Generics's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Jubilant Generics as present at those locations.

Country City Firm Name
India
Roorkee Jubilant Generics Limited





13. LUPIN LTD

Lupin Ltd has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Lupin Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
75MG

tablet Prescription ORAL AB Oct 15, 2012
150MG

tablet Prescription ORAL AB Oct 15, 2012
300MG

tablet Prescription ORAL AB Oct 15, 2012


Manufacturing Plant Locations
New

Lupin Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Lupin Ltd as present at those locations.

Country City Firm Name
India
Aurangabad Lupin Ltd.





14. MACLEODS PHARMS LTD

Macleods Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
300MG

tablet Prescription ORAL AB Oct 3, 2012
150MG

tablet Prescription ORAL AB Oct 3, 2012
75MG

tablet Prescription ORAL AB Oct 3, 2012





15. PRINSTON INC

Prinston Pharmaceutical Inc has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Prinston Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
75MG

tablet Prescription ORAL AB Sep 27, 2012
150MG

tablet Prescription ORAL AB Sep 27, 2012
300MG

tablet Prescription ORAL AB Sep 27, 2012





16. SANDOZ

Sandoz Inc has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Sandoz.

Strength Dosage Form Availability Application Pathway TE code Launch Date
300MG

tablet Prescription ORAL AB Sep 27, 2012
75MG

tablet Prescription ORAL AB Sep 27, 2012
150MG

tablet Prescription ORAL AB Sep 27, 2012


Manufacturing Plant Locations
New

Sandoz's manufacturing plants are situated in 4 countries - Austria, United States, Spain, India. Given below are the details of these plant locations as well as the firm names of Sandoz as present at those locations.

Country City Firm Name
Austria
Langkampfen Sandoz GmbH
Kundl Sandoz GmbH
United States
Princeton Sandoz Inc
East Hanover Sandoz Incorporated
Spain
Les Franqueses Del Valles Sandoz Industrial Products S.A.
Palafolls Sandoz Industrial Products, S.A.
India
Navi Mumbai Sandoz Private Limited





17. SCIEGEN PHARMS INC

Sciegen Pharmaceuticals Inc has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Sciegen Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
150MG

tablet Prescription ORAL AB Dec 7, 2015
75MG

tablet Prescription ORAL AB Dec 7, 2015
300MG

tablet Prescription ORAL AB Dec 7, 2015





18. TEVA PHARMS

Teva Pharmaceuticals Usa has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Teva Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
300MG

tablet Prescription ORAL AB Mar 30, 2012
150MG

tablet Prescription ORAL AB Mar 30, 2012
75MG

tablet Prescription ORAL AB Mar 30, 2012





19. UNICHEM

Unichem Laboratories Ltd has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Unichem.

Strength Dosage Form Availability Application Pathway TE code Launch Date
150MG

tablet Prescription ORAL AB Dec 7, 2015
75MG

tablet Prescription ORAL AB Dec 7, 2015
300MG

tablet Prescription ORAL AB Dec 7, 2015


Manufacturing Plant Locations
New

Unichem's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Unichem as present at those locations.

Country City Firm Name
India
Ghaziabad Unichem Laboratories Ltd.
Mumbai Unichem Laboratories Limited
Kolhapur Unichem Laboratories Limited
Pilerne Bardez Unichem Laboratories Limited
Pithampur Unichem Laboratories Limited
District Raigad Unichem Laboratories Ltd
United States
Hasbrouck Heights Unichem Pharmaceuticals Usa Inc
East Brunswick Unichem Pharmaceuticals USA Inc.





20. UPSHER SMITH LABS

Upsher Smith Laboratories Llc has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Upsher Smith Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
300MG

tablet Discontinued ORAL N/A Sep 27, 2012
75MG

tablet Discontinued ORAL N/A Sep 27, 2012
150MG

tablet Discontinued ORAL N/A Sep 27, 2012





21. WATSON LABS INC

Watson Laboratories Inc has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Watson Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
150MG

tablet Discontinued ORAL N/A Oct 12, 2012
300MG

tablet Discontinued ORAL N/A Oct 12, 2012
75MG

tablet Discontinued ORAL N/A Oct 12, 2012





22. ZYDUS PHARMS USA INC

Zydus Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Zydus Pharms Usa Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
75MG

tablet Prescription ORAL AB Sep 27, 2012
150MG

tablet Prescription ORAL AB Sep 27, 2012
300MG

tablet Prescription ORAL AB Sep 27, 2012